{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:11:18Z","timestamp":1784664678166,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81818-9","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:16:01Z","timestamp":1733285761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris"],"prefix":"10.1038","volume":"14","author":[{"given":"He","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"81818_CR1","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","volume":"63","author":"F Alfonso","year":"2014","unstructured":"Alfonso, F., Byrne, R. A., Rivero, F. & Kastrati, A. Current treatment of in-stent restenosis. J. Am. Coll. Cardiol. 63, 2659\u20132673. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.545 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"81818_CR2","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","volume":"36","author":"RA Byrne","year":"2015","unstructured":"Byrne, R. A., Joner, M. & Kastrati, A. Stent thrombosis and restenosis: What have we learned and where are we going? The Andreas Gr\u00fcntzig lecture ESC 2014. Eur. Heart J. 36, 3320\u20133331. https:\/\/doi.org\/10.1093\/eurheartj\/ehv511 (2015).","journal-title":"Eur. Heart J."},{"key":"81818_CR3","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","volume":"56","author":"GD Dangas","year":"2010","unstructured":"Dangas, G. D. et al. In-stent restenosis in the drug-eluting stent era. J. Am. Coll. Cardiol. 56, 1897\u20131907. https:\/\/doi.org\/10.1016\/j.jacc.2010.07.028 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"81818_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","volume":"46","author":"M Kanbay","year":"2014","unstructured":"Kanbay, M. et al. Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int. Urol. Nephrol. 46, 1619\u20131625. https:\/\/doi.org\/10.1007\/s11255-014-0730-1 (2014).","journal-title":"Int. Urol. Nephrol."},{"key":"81818_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2217\/bmm-2015-0050","volume":"10","author":"MK Akboga","year":"2016","unstructured":"Akboga, M. K. et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark. Med. 10, 375\u2013383. https:\/\/doi.org\/10.2217\/bmm-2015-0050 (2016).","journal-title":"Biomark. Med."},{"key":"81818_CR6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.hlc.2016.02.023","volume":"25","author":"MS Cetin","year":"2016","unstructured":"Cetin, M. S. et al. Monocyte to HDL cholesterol ratio predicts coronary artery Disease Severity and Future Major Cardiovascular adverse events in Acute Coronary Syndrome. Heart Lung Circ. 25, 1077\u20131086. https:\/\/doi.org\/10.1016\/j.hlc.2016.02.023 (2016).","journal-title":"Heart Lung Circ."},{"key":"81818_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00059-015-4393-1","volume":"41","author":"H Kundi","year":"2016","unstructured":"Kundi, H. et al. Association of monocyte\/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Herz 41, 523\u2013529. https:\/\/doi.org\/10.1007\/s00059-015-4393-1 (2016).","journal-title":"Herz"},{"key":"81818_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853890.2016.1168935","volume":"48","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: Evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann. Med. 48, 305\u2013312. https:\/\/doi.org\/10.3109\/07853890.2016.1168935 (2016).","journal-title":"Ann. Med."},{"key":"81818_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2217\/bmm-2016-0071","volume":"10","author":"D Tok","year":"2016","unstructured":"Tok, D. et al. Monocyte to HDL ratio in prediction of BMS restenosis in subjects with stable and unstable angina pectoris. Biomark. Med. 10, 853\u2013860. https:\/\/doi.org\/10.2217\/bmm-2016-0071 (2016).","journal-title":"Biomark. Med."},{"key":"81818_CR10","doi-asserted-by":"publisher","unstructured":"Ucar, F. M. A potential marker of bare metal stent restenosis: Monocyte count - to- HDL cholesterol ratio. BMC Cardiovasc. Disord. 16 https:\/\/doi.org\/10.1186\/s12872-016-0367-3 (2016).","DOI":"10.1186\/s12872-016-0367-3"},{"key":"81818_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/bmm-2016-0069","volume":"10","author":"S Yilmaz","year":"2016","unstructured":"Yilmaz, S. et al. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark. Med. 10, 959\u2013966. https:\/\/doi.org\/10.2217\/bmm-2016-0069 (2016).","journal-title":"Biomark. Med."},{"key":"81818_CR12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/ijgm.S275202","volume":"13","author":"J Nan","year":"2020","unstructured":"Nan, J. et al. The predictive value of Monocyte Count to high-density lipoprotein cholesterol ratio in restenosis after drug-eluting stent implantation. Int. J. Gen. Med. 13, 1255\u20131263. https:\/\/doi.org\/10.2147\/ijgm.S275202 (2020).","journal-title":"Int. J. Gen. Med."},{"key":"81818_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann, F. J. et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur. Heart J. 40, 87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394 (2019).","journal-title":"Eur. Heart J."},{"key":"81818_CR14","doi-asserted-by":"publisher","unstructured":"Byrne, R. A. et al. [2023 ESC Guidelines for the management of acute coronary syndromes]. Giornale italiano di cardiologia () 25, e1\u2013e112, (2006). https:\/\/doi.org\/10.1714\/4191.41785 (2024).","DOI":"10.1714\/4191.41785"},{"key":"81818_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00508-016-1074-x","volume":"128","author":"Z Gabbasov","year":"2016","unstructured":"Gabbasov, Z. et al. Blood level of CD45\u2009+\u2009platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease. Wien. Klin. Wochenschr. 128, 898\u2013905. https:\/\/doi.org\/10.1007\/s00508-016-1074-x (2016).","journal-title":"Wien. Klin. Wochenschr."},{"key":"81818_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/0003319717752245","volume":"70","author":"C Li","year":"2019","unstructured":"Li, C. et al. Evaluation of Preprocedural Laboratory Parameters as predictors of Drug-Eluting Stent Restenosis in Coronary Chronic total occlusion lesions. Angiology 70, 272\u2013278. https:\/\/doi.org\/10.1177\/0003319717752245 (2019).","journal-title":"Angiology"},{"key":"81818_CR17","doi-asserted-by":"publisher","first-page":"41530","DOI":"10.1038\/srep41530","volume":"7","author":"RI Mincu","year":"2017","unstructured":"Mincu, R. I., J\u00e1nosi, R. A., Vinereanu, D., Rassaf, T. & Totzeck, M. Preprocedural C-Reactive protein predicts outcomes after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction a systematic meta-analysis. Sci. Rep. 7, 41530. https:\/\/doi.org\/10.1038\/srep41530 (2017).","journal-title":"Sci. Rep."},{"key":"81818_CR18","first-page":"845","volume":"124","author":"YL Xu","year":"2011","unstructured":"Xu, Y. L. et al. Role of plasma C-reactive protein in predicting in-stent restenosis in patients with stable angina after coronary stenting. Chin. Med. J. 124, 845\u2013850 (2011).","journal-title":"Chin. Med. J."},{"key":"81818_CR19","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.cir.94.6.1247","volume":"94","author":"R Hoffmann","year":"1996","unstructured":"Hoffmann, R. et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94, 1247\u20131254. https:\/\/doi.org\/10.1161\/01.cir.94.6.1247 (1996).","journal-title":"Circulation"},{"key":"81818_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0735-1097(99)00486-6","volume":"35","author":"PH Grewe","year":"2000","unstructured":"Grewe, P. H., Deneke, T., Machraoui, A., Barmeyer, J. & M\u00fcller, K. M. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J. Am. Coll. Cardiol. 35, 157\u2013163. https:\/\/doi.org\/10.1016\/s0735-1097(99)00486-6 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"81818_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1191\/1358863x03vm462oa","volume":"8","author":"FG Welt","year":"2003","unstructured":"Welt, F. G. et al. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc. Med. 8, 1\u20137. https:\/\/doi.org\/10.1191\/1358863x03vm462oa (2003).","journal-title":"Vasc. Med."},{"key":"81818_CR22","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1253\/circj.cj-10-0544","volume":"74","author":"Y Liu","year":"2010","unstructured":"Liu, Y. et al. Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction. Circulation Journal: Official J. Japanese Circulation Soc. 74, 2585\u20132591. https:\/\/doi.org\/10.1253\/circj.cj-10-0544 (2010).","journal-title":"Circulation Journal: Official J. Japanese Circulation Soc."},{"key":"81818_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/01.atv.0000037100.44766.5b","volume":"22","author":"FG Welt","year":"2002","unstructured":"Welt, F. G. & Rogers, C. Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 22, 1769\u20131776. https:\/\/doi.org\/10.1161\/01.atv.0000037100.44766.5b (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"81818_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacc.2003.08.026","volume":"43","author":"D Fukuda","year":"2004","unstructured":"Fukuda, D. et al. Circulating monocytes and in-stent neointima after coronary stent implantation. J. Am. Coll. Cardiol. 43, 18\u201323. https:\/\/doi.org\/10.1016\/j.jacc.2003.08.026 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"81818_CR25","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1161\/01.atv.15.11.1987","volume":"15","author":"GW Cockerill","year":"1995","unstructured":"Cockerill, G. W., Rye, K. A., Gamble, J. R., Vadas, M. A. & Barter, P. J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15, 1987\u20131994. https:\/\/doi.org\/10.1161\/01.atv.15.11.1987 (1995).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"81818_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/atvbaha.108.168690","volume":"28","author":"AJ Murphy","year":"2008","unstructured":"Murphy, A. J. et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28, 2071\u20132077. https:\/\/doi.org\/10.1161\/atvbaha.108.168690 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"81818_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0021-9150(03)00006-6","volume":"168","author":"P Barter","year":"2003","unstructured":"Barter, P., Kastelein, J., Nunn, A. & Hobbs, R. High density lipoproteins (HDLs) and atherosclerosis; The unanswered questions. Atherosclerosis 168, 195\u2013211. https:\/\/doi.org\/10.1016\/s0021-9150(03)00006-6 (2003).","journal-title":"Atherosclerosis"},{"key":"81818_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.Res.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter, P. J. et al. Antiinflammatory properties of HDL. Circul. Res. 95, 764\u2013772. https:\/\/doi.org\/10.1161\/01.Res.0000146094.59640.13 (2004).","journal-title":"Circul. Res."},{"key":"81818_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/01.RES.0000199272.59432.5b","volume":"98","author":"D Seetharam","year":"2006","unstructured":"Seetharam, D. et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circul. Res. 98, 63\u201372. https:\/\/doi.org\/10.1161\/01.RES.0000199272.59432.5b (2006).","journal-title":"Circul. Res."},{"issue":"Suppl 4","key":"81818_CR30","first-page":"7","volume":"83","author":"AM Zeiher","year":"1994","unstructured":"Zeiher, A. M. & Sch\u00e4chinger, V. Coronary endothelial vasodilator dysfunction: Clinical relevance and therapeutic implications. Z. Kardiol. 83 (Suppl 4), 7\u201314 (1994).","journal-title":"Z. Kardiol."},{"key":"81818_CR31","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/hypertensionaha.122.19912","volume":"79","author":"V Trimarco","year":"2022","unstructured":"Trimarco, V. et al. High HDL (high-Density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients. Hypertens. (Dallas Tex. : 1979). 79, 2355\u20132363. https:\/\/doi.org\/10.1161\/hypertensionaha.122.19912 (2022).","journal-title":"Hypertens. (Dallas Tex. : 1979)"},{"key":"81818_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","volume":"7","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations. JAMA Cardiol. 7, 672\u2013680. https:\/\/doi.org\/10.1001\/jamacardio.2022.0912 (2022).","journal-title":"JAMA Cardiol."},{"key":"81818_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jacl.2018.01.014","volume":"12","author":"A Hirata","year":"2018","unstructured":"Hirata, A. et al. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH-JAPAN study. J. Clin. Lipidol. 12, 674\u2013684e675. https:\/\/doi.org\/10.1016\/j.jacl.2018.01.014 (2018).","journal-title":"J. Clin. Lipidol."},{"key":"81818_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-019-0819-z","volume":"18","author":"Z Qin","year":"2019","unstructured":"Qin, Z. et al. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: A single-centre observational cohort study. Cardiovasc. Diabetol. 18, 11. https:\/\/doi.org\/10.1186\/s12933-019-0819-z (2019).","journal-title":"Cardiovasc. Diabetol."},{"key":"81818_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1124\/jpet.123.001878","volume":"388","author":"V Trimarco","year":"2024","unstructured":"Trimarco, V. et al. Long-lasting control of LDL cholesterol induces a 40% reduction in the incidence of cardiovascular events: New insights from a 7-Year study. J. Pharmacol. Exp. Ther. 388, 742\u2013747. https:\/\/doi.org\/10.1124\/jpet.123.001878 (2024).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"81818_CR36","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.atherosclerosis.2023.06.971","volume":"378","author":"R Marfella","year":"2023","unstructured":"Marfella, R. et al. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque. Atherosclerosis 378, 117180. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.06.971 (2023).","journal-title":"Atherosclerosis"},{"key":"81818_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2016.08.007","volume":"253","author":"B Cariou","year":"2016","unstructured":"Cariou, B., Ding, Z. & Mehta, J. L. PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering. Atherosclerosis 253, 275\u2013277. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.08.007 (2016).","journal-title":"Atherosclerosis"},{"key":"81818_CR38","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.2337\/dc21-0939","volume":"44","author":"P Mone","year":"2021","unstructured":"Mone, P. et al. Hyperglycemia drives stent restenosis in STEMI patients. Diabetes care. 44, e192\u2013e193. https:\/\/doi.org\/10.2337\/dc21-0939 (2021).","journal-title":"Diabetes care"},{"key":"81818_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-021-01294-7","volume":"20","author":"L Nesti","year":"2021","unstructured":"Nesti, L., Tric\u00f2, D., Mengozzi, A. & Natali, A. Rethinking pioglitazone as a cardioprotective agent: A new perspective on an overlooked drug. Cardiovasc. Diabetol. 20, 109. https:\/\/doi.org\/10.1186\/s12933-021-01294-7 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"81818_CR40","doi-asserted-by":"publisher","first-page":"22078","DOI":"10.1038\/s41598-023-49367-9","volume":"13","author":"YJ Kim","year":"2023","unstructured":"Kim, Y. J. et al. Mechanistic insights into the anti-restenotic effects of HSP27 and HO1 modulated by reconstituted HDL on neointimal hyperplasia. Sci. Rep. 13, 22078. https:\/\/doi.org\/10.1038\/s41598-023-49367-9 (2023).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81818-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81818-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81818-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:03:26Z","timestamp":1733288606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81818-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81818"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81818-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was submitted to and approved by the Ethics Commission of Chest Hospital, Tianjin University (IRB-SOP-016[F]-001-03), and strictly adhered to the principles of the Declaration of Helsinki. This was a retrospective study, so the content to be included was not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This study does not contain data from any individual person, so consent for publication is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"30175"}}